ibuprofen and famotidine

Generic: ibuprofen and famotidine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ibuprofen and famotidine
Generic Name ibuprofen and famotidine
Labeler camber pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

famotidine 26.6 mg/1, ibuprofen 800 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-315
Product ID 31722-315_097eb368-0559-467f-8a1e-1082e82c15ed
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216814
Listing Expiration 2026-12-31
Marketing Start 2023-03-15

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc] nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa] cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722315
Hyphenated Format 31722-315

Supplemental Identifiers

RxCUI
1100066
UPC
0331722315906
UNII
5QZO15J2Z8 WK2XYI10QM
NUI
N0000000151 N0000175784 N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ibuprofen and famotidine (source: ndc)
Generic Name ibuprofen and famotidine (source: ndc)
Application Number ANDA216814 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 26.6 mg/1
  • 800 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (31722-315-90)
source: ndc

Packages (1)

31722-315-90 90 TABLET in 1 BOTTLE (31722-315-90)

Ingredients (2)

famotidine (26.6 mg/1) ibuprofen (800 mg/1)

Linked Drug Pages (1)

IBUPROFEN AND FAMOTIDINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "097eb368-0559-467f-8a1e-1082e82c15ed", "openfda": {"nui": ["N0000000151", "N0000175784", "N0000000160", "M0001335", "N0000175722"], "upc": ["0331722315906"], "unii": ["5QZO15J2Z8", "WK2XYI10QM"], "rxcui": ["1100066"], "spl_set_id": ["7dc158a2-fdfa-4a5f-8c28-0ce5650991db"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (31722-315-90)", "package_ndc": "31722-315-90", "marketing_start_date": "20230315"}], "brand_name": "IBUPROFEN AND FAMOTIDINE", "product_id": "31722-315_097eb368-0559-467f-8a1e-1082e82c15ed", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "31722-315", "generic_name": "Ibuprofen and famotidine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "IBUPROFEN AND FAMOTIDINE", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "26.6 mg/1"}, {"name": "IBUPROFEN", "strength": "800 mg/1"}], "application_number": "ANDA216814", "marketing_category": "ANDA", "marketing_start_date": "20230315", "listing_expiration_date": "20261231"}